Skip to content

Inspection Record

KDC/ONE Socal Laboratories, LLC — FDA 483 Findings

US FDAInspected 2026-04-14Published 2026-11-12 5 findingsEquipment and facilityQuality unit oversightStability and storageLaboratory and QC controls

Inspectors Thuy Tram L Nguyen · Navneet KaurThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

Equipment and utensils are not cleaned, maintained and sanitized at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

2Equipment and facility

Records are not kept for the cleaning and sanitizing of equipment.

3Quality unit oversight

Each lot of components, drug product containers and closures is not withheld from use until the lot has been sampled, tested, examined, and released by the quality control unit.

4Stability and storage

The written stability program for drug products does not include test intervals based on statistical criteria for each attribute examined to assure valid estimates of stability.

5Laboratory and QC controls

Reserve samples from representative sample lots or batches of drug products selected by acceptable statistical procedures are not examined visually at least (b)(4) for evidence of deterioration.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-11-12. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

KDC/ONE Socal Laboratories, LLC company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.